EMILY ZIEMER: Open Payments
NPI 1356031124 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$623 in 30 payments from 16 companies in 2025. Trend: 2023 $175 · 2024 $1,312 · 2025 $623
Food & beverage: $623
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $176 |
| Novo Nordisk Inc | 4 | $75 |
| Lilly USA, LLC | 4 | $68 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| ABBVIE INC. | 3 | $50 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Viatris Specialty LLC | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Verity Pharmaceuticals Inc. | 1 | $19 |
Products named: FARXIGA, MOUNJARO, Auvelity, BREZTRI, Wegovy, QULIPTA, SPRAVATO, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
